Nose-to-brain drug delivery method works in early trial

04/18/2013 | Xconomy

Impel Neuropharma's nose-to-brain drug delivery method sent a small peptide molecule into the brain in a seven-patient trial, the company's chief scientist said. The technology could have applications in central nervous system disorders and pain relief. Angel investors, the NIH, the Pentagon and Washington state's Life Sciences Discovery Fund provided support for the project.

View Full Article in:

Xconomy

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ